(Q38947451)

English

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).

scientific article published on 18 April 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

viral hepatitis

1 reference

based on heuristic

inferred from title

Olivier Hermine

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Florian van Bömmel

2

object named as

Florian van Bömmel

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

object named as

Vincent Mallet

1

0 references

Darius Moradpour

object named as

Darius Moradpour

9

0 references

11

object named as

Per Ljungman

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Heiner Wedemeyer

10

object named as

Heiner Wedemeyer

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Christopher Doerig

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sven Pischke

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Anna Locasciulli

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Catherine Cordonnier

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Thomas Berg

8

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ECIL-5

12

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

18 April 2016

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

606-617

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

The EBMT activity survey: 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

AASLD guidelines for treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Guide to development of practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Statements from the Taormina expert meeting on occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Host-virus interactions in hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus infection in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

FDA: Increased HBV reactivation risk with ofatumumab or rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus reactivation and alemtuzumab therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of antiviral prophylaxis in HBsAg-negative, anti-HBc positive patients undergoing hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Does chemotherapy cause viral relapse in cancer patients with hepatitis C infection successfully treated with antivirals?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HCV Infection in Very-Long-Term Survivors After Cancer Chemotherapy and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of hepatitis C infection after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic and clinical significance of cryoglobulins. A report of 86 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus in Scottish blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoonotic hepatitis E virus strains in German blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus infections in blood donors, France.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and duration of hepatitis E virus infection in Dutch blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus infection in a hematopoietic stem cell donor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis E infection cured by pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief communication: case reports of ribavirin treatment for chronic hepatitis E.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin for chronic hepatitis E virus infection in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogenic bone marrow transplantation with a donor presenting with an acute hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis associated aplastic anemia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatitis A virus infection without IgM antibodies to hepatitis A virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib induced hepatitis B reactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900118-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(16)00118-3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38947451&oldid=1673242161"